Digoxin toxicity: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
*Positive inotropic effect | *Positive inotropic effect | ||
** Inhibits Na-K pump -> incr extracelluar K, incr intracellular Na -> incr intracellular Ca | **Inhibits Na-K pump -> incr extracelluar K, incr intracellular Na -> incr intracellular Ca | ||
*Increases vagal tone | *Increases vagal tone | ||
** | **Can lead to bradyarrhythmias (esp in young) | ||
*Increases automaticity | *Increases automaticity | ||
** | **Can lead to tachyarrhythmias (esp in elderly) | ||
*Renally cleared | *Renally cleared | ||
*Hemodialysis does not work | *Hemodialysis does not work | ||
| Line 13: | Line 13: | ||
== Risk Factors == | == Risk Factors == | ||
*Electrolyte | *Electrolyte Imbalance | ||
**Hypokalemia, hypomagnesemia, Hypercalcemia | **Hypokalemia, hypomagnesemia, Hypercalcemia | ||
*Hypovolemia | *Hypovolemia | ||
*Renal insufficiency | |||
*Cardiac ischemia | *Cardiac ischemia | ||
*Hypothyroidism | *Hypothyroidism | ||
*Meds | *Meds | ||
| Line 25: | Line 25: | ||
Cardiac | Cardiac | ||
*Any type of dysrhythmia is possible except for rapidly conducted atrial arrhythmias | *Any type of dysrhythmia is possible except for rapidly conducted atrial arrhythmias | ||
*Most common: | *Most common: | ||
| Line 30: | Line 31: | ||
**Bradycardia | **Bradycardia | ||
*Digitalis Effect | *Digitalis Effect | ||
** T wave changes | **T wave changes | ||
** QT interval shortening | **QT interval shortening | ||
** Scooped ST segments with depression in lateral leads | **Scooped ST segments with depression in lateral leads | ||
GI | GI | ||
*Nausea/vomiting | *Nausea/vomiting | ||
*Abdominal pain | *Abdominal pain | ||
Neuro | Neuro | ||
*Confusion | *Confusion | ||
*Weakness | *Weakness | ||
| Line 45: | Line 48: | ||
**Scotomas | **Scotomas | ||
*Delirium | *Delirium | ||
| Line 50: | Line 54: | ||
*Dig level | *Dig level | ||
**Normal = 0.8-2 ng/mL | **Normal = 0.8-2 ng/mL (ideal = 0.7-1.1) | ||
***May have toxicity even with "therapeutic" levels | ***May have toxicity even with "therapeutic" levels | ||
**Measure serum level at least 6 hours after acute ingestion, immediately for chronic ingestion | **Measure serum level at least 6 hours after acute ingestion (if stable), immediately for chronic ingestion | ||
***If measure before this may be falsely elevated due to incomplete drug distribution | ***If measure before this may be falsely elevated due to incomplete drug distribution | ||
*Chemistry | *Chemistry | ||
**Hyperkalemia level correlates with degree of toxicity | **Hyperkalemia level correlates with degree of toxicity | ||
*** Hyperkalemia does not cause death; lowering K+ does not reduce mortality | ***Hyperkalemia does not cause death; lowering K+ does not reduce mortality | ||
**Hypokalemia increases susceptibility in chronic toxicity | **Hypokalemia increases susceptibility in chronic toxicity | ||
**Hypomagnesemia is common | **Hypomagnesemia is common | ||
*Cr/BUN | *Cr/BUN | ||
*Urine output | *Urine output | ||
* ECG (serial) | *ECG (serial) | ||
| Line 83: | Line 88: | ||
***CHF, a fib w/ RVR | ***CHF, a fib w/ RVR | ||
**Hypokalemia | **Hypokalemia | ||
*Initial response time ~ 20min, peak effect ~ 90min | |||
*How To Use | *How To Use | ||
| Line 90: | Line 96: | ||
***Peds dose | ***Peds dose | ||
****5 vials over 30 min | ****5 vials over 30 min | ||
****Repeat dose if clinical response is inadequate | ****Repeat dose if clinical response is inadequate | ||
**'''2. Amount ingested is known but digoxin level is unknown''' | **'''2. Amount ingested is known but digoxin level is unknown''' | ||
| Line 102: | Line 107: | ||
**Give half the recommended dose | **Give half the recommended dose | ||
***Otherwise may unmask the condition for which the pt is taking digoxin | ***Otherwise may unmask the condition for which the pt is taking digoxin | ||
**'''5. Cardiac Arrest''' | |||
***20 vials administered undiluted by IV bolus | |||
'''Activated charcoal''' | '''Activated charcoal''' | ||
*Questionable efficacy | |||
*Only an adjunctive tx; NOT an alternative to fab fragment therapy | *Only an adjunctive tx; NOT an alternative to fab fragment therapy | ||
*Consider only if present within | *Consider only if present within 1 hr of ingestion | ||
*1g/kg (max 50g) | *1g/kg (max 50g) | ||
'''Rhythm Disturbances''' | '''Rhythm Disturbances''' | ||
* | *Fab fragments is the agent of choice for all dysrhythmias! | ||
*Bradyarrhythmias (symptomatic) | |||
**Atropine 0.5mg IV | **Atropine 0.5mg IV | ||
**Pacing | **Pacing | ||
*Tachyarrhythmias | *Tachyarrhythmias | ||
**Lidocaine | **Lidocaine | ||
***1-3mg/kg over several minutes, followed by 1-4mg/min | |||
**Phenytoin | **Phenytoin | ||
**Cardioversion | ***May enhance AV conduction | ||
***Infuse at 25-50 mg/min to a loading dose of 10-15mg/kg | |||
*Cardioversion | |||
**Consider lower energy settings (25-50J) | |||
'''Hyperkalemia''' | |||
*Treat with Fab, not with usual meds | |||
*Treat with Fab, not with usual meds | |||
**Once fab is given hyperkalemia will rapidly correct | **Once fab is given hyperkalemia will rapidly correct | ||
**Aggressive tx with potassium-lowering agents could cause sig hypokalemia following therapy | |||
*If Fab is not available and hyperkalemia is life-threatening then treat | |||
*Calcium is controversial (some say dangerous, others say not) | |||
'''Hypokalemia''' | '''Hypokalemia''' | ||
* | |||
*Chronic intoxication | |||
**Raise level to 3.5-4 | |||
*Acute intoxication | |||
**Do not treat (likely that potassium level is rapidly rising) | |||
'''Hypomagnesemia''' | '''Hypomagnesemia''' | ||
*Treat | *Treat with 1-2g over 10-20 min | ||
**Monitor for resp depresion | |||
**Avoid in pts with: | |||
***Renal failure | |||
***Bradydysrhythmias/conduction blocks | |||
== Source == | == Source == | ||
Rosen's | Rosen's | ||
[[Category:Tox]] <br/> | |||
Revision as of 18:06, 21 March 2011
Background
- Positive inotropic effect
- Inhibits Na-K pump -> incr extracelluar K, incr intracellular Na -> incr intracellular Ca
- Increases vagal tone
- Can lead to bradyarrhythmias (esp in young)
- Increases automaticity
- Can lead to tachyarrhythmias (esp in elderly)
- Renally cleared
- Hemodialysis does not work
- 1 fab vial binds 0.5mg of digoxin
Risk Factors
- Electrolyte Imbalance
- Hypokalemia, hypomagnesemia, Hypercalcemia
- Hypovolemia
- Renal insufficiency
- Cardiac ischemia
- Hypothyroidism
- Meds
- CCBs, amiodarone
Clinical Manifestations
Cardiac
- Any type of dysrhythmia is possible except for rapidly conducted atrial arrhythmias
- Most common:
- PVCs
- Bradycardia
- Digitalis Effect
- T wave changes
- QT interval shortening
- Scooped ST segments with depression in lateral leads
GI
- Nausea/vomiting
- Abdominal pain
Neuro
- Confusion
- Weakness
- Visual disturbances
- Yellow halos
- Scotomas
- Delirium
Work-Up
- Dig level
- Normal = 0.8-2 ng/mL (ideal = 0.7-1.1)
- May have toxicity even with "therapeutic" levels
- Measure serum level at least 6 hours after acute ingestion (if stable), immediately for chronic ingestion
- If measure before this may be falsely elevated due to incomplete drug distribution
- Normal = 0.8-2 ng/mL (ideal = 0.7-1.1)
- Chemistry
- Hyperkalemia level correlates with degree of toxicity
- Hyperkalemia does not cause death; lowering K+ does not reduce mortality
- Hypokalemia increases susceptibility in chronic toxicity
- Hypomagnesemia is common
- Hyperkalemia level correlates with degree of toxicity
- Cr/BUN
- Urine output
- ECG (serial)
Treatment
Fab Fragment Therapy
- Indications
- Severe rhythm disturbances refractory to conventional therapy
- End-organ dysfunction
- Hyperkalemia >5 after acute overdose
- Pacemaker (may mask cardiac dysrhythmia)
- Consider for:
- Dig level > 10 in acute ingestion
- Dig level > 4 in chronic ingestion
- If adult acutely ingests > 10mg
- If child acutely ingests > 4mg
- Side effects
- Allergic reaction
- Withdrawal of dig effect:
- CHF, a fib w/ RVR
- Hypokalemia
- Initial response time ~ 20min, peak effect ~ 90min
- How To Use
- 1. Neither amount ingested nor digoxin level are known:
- Adult dose
- 10 vials over 30 min
- Peds dose
- 5 vials over 30 min
- Repeat dose if clinical response is inadequate
- Adult dose
- 2. Amount ingested is known but digoxin level is unknown
- Step 1: Calculate total body load (TBL)
- TBL = dose (in mg) ingested
- Step 2: Calculate number of vials needed
- Number of vials = TBL X 2 (round up to nearest whole number)
- 3. Steady state digoxin level is known
- Number of vials = (dig level(in ng/mL) X pt wt) / 100
- 4. Chronic toxicity without severe signs
- Give half the recommended dose
- Otherwise may unmask the condition for which the pt is taking digoxin
- 5. Cardiac Arrest
- 20 vials administered undiluted by IV bolus
- 1. Neither amount ingested nor digoxin level are known:
Activated charcoal
- Questionable efficacy
- Only an adjunctive tx; NOT an alternative to fab fragment therapy
- Consider only if present within 1 hr of ingestion
- 1g/kg (max 50g)
Rhythm Disturbances
- Fab fragments is the agent of choice for all dysrhythmias!
- Bradyarrhythmias (symptomatic)
- Atropine 0.5mg IV
- Pacing
- Tachyarrhythmias
- Lidocaine
- 1-3mg/kg over several minutes, followed by 1-4mg/min
- Phenytoin
- May enhance AV conduction
- Infuse at 25-50 mg/min to a loading dose of 10-15mg/kg
- Lidocaine
- Cardioversion
- Consider lower energy settings (25-50J)
Hyperkalemia
- Treat with Fab, not with usual meds
- Once fab is given hyperkalemia will rapidly correct
- Aggressive tx with potassium-lowering agents could cause sig hypokalemia following therapy
- If Fab is not available and hyperkalemia is life-threatening then treat
- Calcium is controversial (some say dangerous, others say not)
Hypokalemia
- Chronic intoxication
- Raise level to 3.5-4
- Acute intoxication
- Do not treat (likely that potassium level is rapidly rising)
Hypomagnesemia
- Treat with 1-2g over 10-20 min
- Monitor for resp depresion
- Avoid in pts with:
- Renal failure
- Bradydysrhythmias/conduction blocks
Source
Rosen's
